VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for…
Blog Archives
PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity
Tagged with: assessment, bradykinesia, clinical trials, company, dbs, deep brain stimulation, development, dyskinesia, gait, growth, kinesia, movement disorders, neuroprotective, parkinson's disease, patent, pd, rigidity, telemedicine, tremor
Objective Motion Sensor Assessment Highly Correlated with Scores of Global Levodopa-Induced Dyskinesia in Parkinson’s Disease
T. Mera, M. Burack, J. Giuffrida J Parkinsons Dis. 2013 Jan 1;3(3):399-407.
Tagged with: assessment, dyskinesia, levodopa, levodopa-induced dyskinesias, motion sensor, parkinson's disease, pd
Tradeshow Event: Partnership in Clinical Trials
The Mirage Hotel Las Vegas, NV March 31 – April 2 2014 Conference home page We will be exhibiting at booth #1305 . We will be demonstrating out Kinesia HomeView and ProView systems. From the 2013 event: This year’s event…
PRESS RELEASE: GLNT Awarded Patent For Sensor Based Continuous Parkinson’s Assessment During Daily Activities
VIEW PRESS RELEASE [PDF] 03 DEC 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of continuous monitoring of motor…
PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million to Develop Continuous Dyskinesia Monitoring Technology for Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The…
Quantitative assessment of levodopa-induced dyskinesia using automated motion sensing technology
T. Mera, M. Burack, J. Giuffrida Conf Proc IEEE Eng Med Biol Soc. 2012.
PRESS RELEASE: GLNT Begins Clinical Study to Demonstrate High Sensitivity Motor Symptom Detection in Parkinson’s Disease
VIEW PRESS RELEASE [PDF] March 23, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have begun a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with…
PRESS RELEASE: GLNT Awarded Patent for Technology to Assess Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 8MAR2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have received allowance of claims from the U.S. Patent Office for an application covering their Movement Disorder Monitoring System and Method for quantitative assessment…
Automated Parkinson’s Disease Gait and Balance Assessment for Optimization of Deep Brain Stimulation
T. Mera, D. Filipkowski, Riley R, Walter B, Gunzler S, J. Giuffrida International Congress of Parkinson’s Disease and Movement Disorders, Toronto, CA 2011
Tagged with: assessment, balance, dbs, deep brain stimulation, gait, movement disorders, parkinson's disease, pd
Correlation between Kinesia system assessments and clinical tremor scores in patients with essential tremor
M. Giovanni, J. Giuffrida, O. Adam, A. Davidson, J. Jankovic Mov Disord. 2010 Sep 15;25(12):1938-43